Frederick M. Hudson - 22 Feb 2022 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
22 Feb 2022
Transactions value $
$0
Form type
4
Filing time
24 Feb 2022, 20:24:03
Previous filing
23 Feb 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 22.3K 22 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +6.85K $0.00 6.85K 22 Feb 2022 Common Stock 6.85K $32.20 Direct
transaction SUPN Restricted Stock Units Award $0 +3.88K $0.00 3.88K 22 Feb 2022 Common Stock 3.88K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F2 These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023.

Remarks:

Exhibit 24 - Power of Attorney